Zobrazeno 1 - 10
of 73
pro vyhledávání: '"CHONDROGUARD"'
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 6, Pp 109-114 (2023)
A significant proportion of patients who have had COVID-19 continue to suffer from persistent symptoms such as severe weakness, shortness of breath, joint pain, mood swings and memory impairment during the recovery phase. More than half of the patien
Externí odkaz:
https://doaj.org/article/1608c1e303b4465d965dfcdd7a8afca4
Autor:
Al. B. Danilov, A. M. Lila, Yo. N. Majidova, O. A. Gromova, O. N. Tkacheva, I. V. Sarvilina, A. Yu. Kochish, A. G. Nazarenko, N. V. Zagorodniy, T. B. Minasov, L. I. Alekseeva, E. A. Taskina, Yu. V. Kotovskaya, E. N. Dudinskaya, A. V. Rozanov, E. Yu. Solovieva, O. A. Shavlovskaya, M. N. Sharov, P. R. Kamchatnov, A. P. Rachin, E. R. Barantsevich, D. A. Iskra, E. Z. Yakupov, F. I. Devlikamova, A. E. Barulin, M. V. Nesterova, T. G. Sakovets, A. N. Barinov, I. N. Dolgova, N. V. Zabolotskikh, E. V. Zonova, L. A. Shchepankevich, V. A. Parfenov, A. T. Dzhurabekova, S. Z. Khakimova
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 2, Pp 134-146 (2023)
In recent decades, there has been an increase in the prevalence and medical and social burden of osteoarthritis (OA) and nonspecific back pain in all countries of the world. The First Multidisciplinary Bilateral Russia-Uzbekistan Expert Council prese
Externí odkaz:
https://doaj.org/article/93f690548854451da4bf63e3129a78f5
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 1, Pp 110-118 (2023)
Modern fundamental and clinical studies show that chondroprotector molecules (chondroitin sulfate – CS; glucosamine sulfate – GS) can be useful in the treatment of neuroinflammation and so-called "inflammageing" – chronic, low-grade systemic in
Externí odkaz:
https://doaj.org/article/330798984bbe4670a6a3b5ec3147211a
Publikováno v:
Современная ревматология, Vol 16, Iss 3, Pp 67-74 (2022)
Objective: to evaluate the efficacy and safety of the parenteral form of pharmaceutical chondroitin sulfate (CS) in neuroimmune joint damage in patients with early knee osteoarthritis (OA) in long COVID.Patients and methods. An open prospective contr
Externí odkaz:
https://doaj.org/article/d33e1b30eee54f28a419b095aa4a7b56
Autor:
article Editorial
Publikováno v:
Современная ревматология, Vol 17, Iss 2, Pp 125-126 (2023)
On April 1, 2023, experts presented a resolution of the First Multidisciplinary Bilateral Russia–Uzbekistan Expert Council, dedicated to innovations in the prediction and personalized prevention of degenerative-dystrophic diseases of the joints and
Externí odkaz:
https://doaj.org/article/bf6d552a19cc40979569ac2ccfcb34fa
Autor:
Olga A. Shavlovskaya
Publikováno v:
Терапевтический архив, Vol 93, Iss 12, Pp 1551-1555 (2021)
Of undoubted interest is the search for new drugs comparable in effectiveness to nonsteroidal anti-inflammatory drugs (NSAIDs), but with a safer application profile. NSAIDs are characterized by a good analgesic effect due to the modulation of prostag
Externí odkaz:
https://doaj.org/article/7120092fef724c589b98b3b47e5b4094
Publikováno v:
Фармакоэкономика, Vol 14, Iss 3, Pp 407-414 (2021)
Osteoarthritis is considered a peripheral joint disease and is often ignored when discussing the prevalence and treatment of back pain. Traditionally, clinical guidelines from various countries are devoted to the treatment of nonspecific back pain (l
Externí odkaz:
https://doaj.org/article/96df4a65160140faa59f15240f67adfc
Publikováno v:
Современная ревматология, Vol 15, Iss 4, Pp 120-125 (2021)
Currently chondroitin sulfate (CS) is the most studied drug from the group of «chondroprotectors». The article shows the role of CS in the treatment of osteoarthritis (OA): mechanism of action, clinical efficacy and safety in patients with OA with
Externí odkaz:
https://doaj.org/article/eb0d8ed317034dfcbaf48f34db740145
Publikováno v:
Современная ревматология, Vol 15, Iss 1, Pp 136-143 (2021)
A systematic analysis of 37 post-genomic osteoarthritis (OA) studies (genomics, transcriptomics, proteomics, metabolomics) allowed to isolate 483 genes and corresponding proteins, their levels and activity disturbances are involved in the pathogenesi
Externí odkaz:
https://doaj.org/article/38f5468250ef46d491f205a45c6c6629
Autor:
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, L. V. Vasilyeva, Ye. F. Yevstratova, А. N. Gromov
Publikováno v:
Фармакоэкономика, Vol 13, Iss 4, Pp 452-462 (2021)
The article focuses on the review of a pharmacotherapeutic approach to the therapy of hand osteoarthritis (HO). Apart from non-steroid antiinflammatory drugs (NSAID), promising therapeutic means of HO therapy include steroid drugs, chondroitin sulfat
Externí odkaz:
https://doaj.org/article/2a27068f885144c8a00124863acb03f5